IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 17027 
Small font sizeDefault font sizeIncrease font size
Navigate Here
 »   Next article
 »   Previous article
 »   Table of Contents

Resource Links
 »   Similar in PUBMED
 »  Search Pubmed for
 »  Search in Google Scholar for
 »Related articles
 »   Citation Manager
 »   Access Statistics
 »   Reader Comments
 »   Email Alert *
 »   Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed4757    
    Printed190    
    Emailed4    
    PDF Downloaded168    
    Comments [Add]    
    Cited by others 5    

Recommend this journal

 

 CASE REPORT
Year : 2010  |  Volume : 42  |  Issue : 3  |  Page : 189-191

Zidovudine-induced reversible pure red cell aplasia


1 Departments of Medicine and Pathology, Kasturba Medical College, Manipal University, Manipal, Karnataka, India
2 Division of Medicine, Lyell McEwin Hospital, Elizabeth Vale, South Australia

Correspondence Address:
Rohith Valsalan
Division of Medicine, Lyell McEwin Hospital, Elizabeth Vale, South Australia

Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0253-7613.66845

Rights and Permissions

Hematological abnormalities are frequent among human immunodeficiency virus (HIV)-infected patients and may be directly attributable to the virus or may be caused by opportunistic infections, neoplasms or drugs that cause bone marrow suppression or hemolysis. Pure red cell aplasia (PRCA) is an uncommon hematological disorder that causes anemia. We report a 37-year-old male with HIV infection who developed PRCA 6 weeks after commencing Zidovudine and recovered following cessation of the drug. This is the first case of Zidovudine-induced PRCA reported from the Indian subcontinent.






[FULL TEXT] [PDF]*


        
Print this article     Email this article

Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer | Privacy Notice
Online since 20th July '04
Published by Wolters Kluwer - Medknow